The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma
- 7 December 2017
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 29 (1) , 21-34
Abstract
Brain glioma is one of the most common and devastating intracranial malignancies with a high mortality. Chemotherapy for brain glioma is not ideal due to blood brain barrier (BBB) and multidrug resistance (MDR). The objectives of the present study were to develop a kind of RGD (Arg-Gly-Asp) tripeptide modified vinorelbine plus tetrandrine liposomes to achieve BBB transportation, MDR reversion and glioma cell targeting simultaneously. The studies were performed on glioma cells, resistant glioma cells and glioma-bearing mice. Results showed that the constructed liposomes with suitable physicochemical properties could significantly enhance the transport across BBB, obviously accumulate in glioma cells, and exhibit evident capabilities in diminishing brain glioma in mice. Action mechanism studies indicated that the enhanced anticancer efficacy could be attribute to the follows: prolonged elimination half-life (7.093 ± 1.311 h); increased AUC0–24 h (28.92 ± 2.66 mg/L*h); transporting across BBB; enhanced cellular uptake; down-regulation on P-gp (0.49 ± 0.06 fold); inducing apoptosis via activating caspase 8, 9, and 3 (2.40 ± 0.22, 3.57 ± 0.29, and 4.33 ± 0.30 folds, respectively). In conclusion, the RGD modified vinorelbine plus tetrandrine liposomes may offer a promising therapeutic strategy for treatment of brain glioma.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 36 references indexed in Scilit:
- Hyperbaric oxygen preconditioning ameliorates blood-brain barrier damage induced by hypoxia through modulation of tight junction proteins in an in vitro modelCroatian Medical Journal, 2016
- Metronomic Oral Vinorelbine in Advanced Breast Cancer and Non-Small-Cell Lung Cancer: Current Status and Future DevelopmentFuture Oncology, 2015
- Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistanceInternational Journal of Pharmaceutics, 2015
- Glioma Targeting and Anti-glioma Effect of Interleukin 13 Peptide and RGD Peptide Dual Functionalized NanoparticlesCurrent Pharmaceutical Biotechnology, 2014
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in ratBiomaterials, 2012
- Dual-Targeting Topotecan Liposomes Modified with Tamoxifen and Wheat Germ Agglutinin Significantly Improve Drug Transport across the Blood−Brain Barrier and Survival of Brain Tumor-Bearing AnimalsMolecular Pharmaceutics, 2009
- Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluationsJournal of Controlled Release, 2009
- The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan HorsesClinical Cancer Research, 2007
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007